Use of serum uPA change to predict PFS and overall survival in first-line trastuzumab-treated breast cancer

Autor:	Walter P. Carney, A. Lipton, Kim Leitzel, Peter J. Hamer, U. Anyanwu, N. Jamshidi, E. Fuchs, H. Y. Hou, Wolfgang J. Köstler, Suhail M. Ali
Rok vydání:	2010
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry First line medicine.disease Surgery Breast cancer Trastuzumab Internal medicine medicine Overall survival skin and connective tissue diseases business neoplasms medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:1050-1050
ISSN:	1527-7755 0732-183X
Popis:	1050 Background: About half of patients with HER2-positive breast cancer will respond to first-line trastuzumab-containing therapy, but of these most will progress within a year with acquired resis...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6372f397f3d6a6382f7a1e02d0c55701 https://doi.org/10.1200/jco.2010.28.15_suppl.1050 Zobrazit plný text záznamu